| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |